Can high-sensitivity c-reactive protein and ferritin predict functional outcome in acute ischemic stroke? a prospective study

Topics in Stroke Rehabilitation

Volumn 20, Issue 6, 2013, Pages 528-536

  Ozkan, Aslihan ^a   Yemisci, Oya ^b   Saracgil Cosar, Sacide ^b   Oztop, Pinar ^b   Turhan, Nur ^c  

^a Kadirli Government Hospital   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c BAYINDIR HOSPITAL   (Turkey)

Author keywords

ferritin; functional disability; high sensitivity C reactive protein; ischemic stroke

Indexed keywords

C REACTIVE PROTEIN; FERRITIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; DISABILITY SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; FUNCTIONAL INDEPENDENCE MEASURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PROSPECTIVE STUDY; AGED; DISABILITY; ISCHEMIA; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME;

ADULT; AGED; C-REACTIVE PROTEIN; DISABILITY EVALUATION; FEMALE; FERRITINS; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 85039650229     PISSN: 10749357     EISSN: 19455119     Source Type: Journal    
DOI: 10.1310/tscir2001-528     Document Type: Article

References (31)

1. Youn CS, Choi SP, Kim SH, et al. Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. Am J Emerg Med. 2012;30:124-128.
2. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke. 2001;32:917-924.
3. Giannopoulos S, Kosmidou M, Hatzitolios AI, et al. Measurements of endothelin-1, C-reactive protein and fi brinogen plasma levels in patients with acute ischemic stroke. Neurol Res. 2008;30:727-730.
4. Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30:981-988.
5. Anuk T, Assayag EB, Rotstein R, et al. Prognostic implications of admission infl ammatory profi le in acute ischemic neurological events. Acta Neurol Scand. 2002;106:196-199.
6. Di Napoli M, Papa F, Bocola V. Prognostic infl uence of increased C-reactive protein and fi brinogen levels in ischemic stroke. Stroke. 2001;32:133-138.
7. Winbeck K, Poppert H, Etgen T, et al. Prognostic relevance of early serial C-reactive protein measurements after fi rst ischemic stroke. Stroke. 2002;33:2459-2464.
8. Di Napoli M, Schwaninger M, Cappelli R, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: A statement for healthcare professionals from the CRP pooling project members. Stroke. 2005;36:1316-1329.
9. Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The Bergen stroke study. BMC Neurol. 2009;9:18-19.
10. Smith CJ, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of infl ammation in the fi rst week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;4:2-8.
11. Hertog HM, Rossum JA, Worp HB, et al. C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. J Neurol. 2009;256:2003-2008.
12. Rajeshwar K, Kaul S, Al-Hazzani A, et al. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: Correlation with clinical outcome. Infl ammation. 2012;35:978-984.
13. Davalos A, Castillo J, Marrugat J, et al. Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology. 2000;54: 1568-1574.
14. Armengou A, Davalos A, Fernandez-Real JM, et al. Serum ferritin concentrations are not modifi ed in the acute phase of ischemic stroke. Stroke. 1998;29:258-260.
15. Aho K, Harmsen P, Hatano S, Marguardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: Results of a WHO collaborative study. Bull World Health Organ. 1980;58:113-130.
16. Grundy SM. Approach to lipoprotein management in 2001 National Cholesterol Guidelines. Am J Cardiol. 2002;17:11i-21i.
17. American Diabetes Association. Clinical practice recommendations 2000. Diabetes Care. 2000;23:S1-S116.
18. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifi able subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
19. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: A clinical examination scale. Stroke. 1989;20:864-870.
20. Braddom RL, ed. Physical Medicine and Rehabilitation. 3rd ed. Philadelphia: Saunders; 2007.
21. Collen FM, Wade DT, Bradshaw CM. Mobility after stroke: Reliability of measures of impairment and disability. Int Disabil Stud. 1990;12:6-9.
22. Canova CR, Courtin C, Reinhart WH. C-reactive protein (CRP) in cerebrovascular events. Atherosclerosis. 1999;147:49-53.
23. Ladenvall C, Jood K, Blomstrand C, et al. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke. 2006;37:2018-2023.
24. Rabadi MH, Coar PL, Lukin M, Lesser M, Blass JP. Admission C-reactive protein does not predict functional outcomes in patients with strokes in a subacute rehabilitation unit. Am J Phys Med Rehabil. 2008;87:731-739.
25. Ryu SR, Choi IS, Bian RX, et al. The effect of C-reactive protein on functional outcome in ischemic stroke patients. Int J Neurosci. 2009;119:336-344.
26. Erdemoglu AK, Ozbakir S. Serum ferritin levels and early prognosis of stroke. Eur J Neurol. 2002;9: 633-637.
27. Corso G, Bottachi E, Brusa A, et al. Is there a prognostic role of C-reactive protein in ischemic stroke? Acta Neurol Scand. 2010;122:209-216.
28. Chakraborty B, Vishnoi G, Goswami B, et al. Lipoprotein(a), ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in North Indian patients [published online ahead of print December 14, 2012]. J Stroke Cerebrovasc Dis.
29. Song IU, Kim JS, Kim YI, et al. Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis. 2009;28: 545-550.
30. Petzold A, Michel P, Stock M, et al. Glial and axonal body fl uid biomarkers are related to infarct volume, severity, and outcome. J Stroke Cerebrovasc Dis. 2008;17;196-203.
31. Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis. 2002;162:217-219.